Recent News

• 04.23.2025 - Inspira Achieves above 99% Gas Exchange Efficiency in VORTX™ Technology In-Vivo Animal Testing
• 04.15.2025 - Inspira Technologies Generates First Revenues from Deployment of INSPIRA ART100 Systems
• 04.07.2025 - Inspira Technologies Announces Successful Treatment of First Patient with INSPIRA ART100 at Westchester Medical Center
• 03.25.2025 - Inspira Technologies Announces Successful Installation of INSPIRA ART100 Systems in Premier U.S. Hospital
• 03.14.2025 - Inspira Technologies Releases CEO Update: Major Milestones Signal Next-Level Respiratory Care

Recent Filings

• 04.15.2025 - EX-99.1 EX-99.1
• 04.15.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 04.10.2025 - 424B5 Prospectus [Rule 424(b)(5)]
• 04.10.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 04.07.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 04.07.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 04.07.2025 - EX-99.1 EX-99.1
• 04.07.2025 - EX-99.1 EX-99.1
• 03.28.2025 - 20-F/A Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
• 03.25.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]